Eventide Asset Management LLC Has $97.28 Million Holdings in Lam Research Corporation $LRCX

Eventide Asset Management LLC increased its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 35.2% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 996,897 shares of the semiconductor company’s stock after buying an additional 259,702 shares during the period. Lam Research accounts for 1.7% of Eventide Asset Management LLC’s holdings, making the stock its 12th biggest holding. Eventide Asset Management LLC owned about 0.08% of Lam Research worth $97,281,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. IMG Wealth Management Inc. bought a new position in shares of Lam Research in the 2nd quarter worth about $26,000. Howard Hughes Medical Institute acquired a new stake in Lam Research during the second quarter worth approximately $27,000. Strategic Wealth Investment Group LLC bought a new stake in Lam Research in the second quarter worth approximately $29,000. REAP Financial Group LLC bought a new position in shares of Lam Research during the 2nd quarter worth approximately $31,000. Finally, 1 North Wealth Services LLC acquired a new stake in shares of Lam Research during the 1st quarter worth approximately $36,000. Institutional investors own 84.61% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on LRCX shares. Susquehanna increased their target price on shares of Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research note on Thursday, October 23rd. Barclays set a $142.00 price objective on shares of Lam Research and gave the stock an “equal weight” rating in a research report on Monday, October 20th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Lam Research in a research note on Monday. The Goldman Sachs Group raised their price objective on Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, October 8th. Finally, Morgan Stanley upped their target price on Lam Research from $137.00 to $158.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 2nd. Twenty-six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $152.87.

Insider Transactions at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bethany Mayer sold 1,298 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 102,608 shares of company stock worth $14,916,496 over the last quarter. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Stock Performance

Shares of LRCX stock opened at $160.52 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The firm has a market cap of $201.62 billion, a price-to-earnings ratio of 35.36, a P/E/G ratio of 1.73 and a beta of 1.77. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $169.69. The firm’s 50-day simple moving average is $152.53 and its two-hundred day simple moving average is $119.99.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. Lam Research’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. Lam Research’s payout ratio is presently 22.91%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.